- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionCREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates through human trials.STAT · 2mo ago↗ source
- STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionRegenxbio said its experimental gene therapy for Duchenne muscular dystrophy succeeded in a trial, paving the way for a submission to the FDA.STAT · 2mo ago↗ source
- STAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chiefKyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the agency.STAT · 2mo ago